[INQ. NO. 2610E02] JSDR has been focused on addressing skin problems that are difficult to treat with conventional aesthetic procedures — such as deep wrinkles and depressed scars — by developing the SDR treatment method and its dedicated medical equipment. Rather than simply delivering energy to the skin, the device focuses on enabling medical professionals to precisely control the process of micro-injecting necessary substances into specific locations.
JUVGEN, the company’s flagship product, is designed for SDR procedures that involve the micro-injection of CO₂ and hyaluronic acid (HA) into the dermal layer of the skin. JSDR explains that the core principle of SDR is inducing skin tissue regeneration and collagen formation through the precise delivery of these two substances to the treatment area.
A key feature of JUVGEN is its precision in micro-injection. The device allows for injection volume control in increments as small as 0.001cc, enabling medical professionals to fine-tune treatment parameters according to the specific area and the patient’s skin condition. It is designed to ensure consistent management of injection volume and placement, which is crucial for aesthetic procedures requiring precision over relatively small areas, such as deep wrinkles and sunk scars.
Additionally, by integrating the use of both CO₂ and HA into a single system, the device minimizes potential inconsistencies associated with repetitive manual steps and streamlines the treatment workflow. The company developed its product by combining the precision control capabilities of the equipment with a procedure that previously relied solely on the practitioner’s experience, thereby enhancing the reproducibility and ease of use of SDR treatments.
The starting point for product development was the treatment method itself rather than the equipment alone. After researching Autologous Dermal Regeneration (SDR) — a technique applicable to deep wrinkles and depressed scars — JSDR developed JUVGEN, a dedicated device designed to enable medical professionals to perform the procedure with greater accuracy and consistency.
Consequently, JUVGEN was designed as a comprehensive system that integrates the treatment protocol with the hardware, rather than serving merely as an injection device. Medical professionals can configure necessary treatment parameters and monitor progress via the touchscreen on the front of the unit, while an intuitive user interface ensures quick access to essential functions during the procedure.
JUVGEN’s handpiece incorporates a dual-chamber syringe system that combines two injection pathways into a single structure. This design enables the precise delivery of CO₂ and HA during the procedure and minimizes the need for medical professionals to repeatedly switch instruments. In particular, the section of the handpiece that makes direct contact with the skin is designed to allow for stable operation, while enabling the practitioner to verify the injection site. A key feature is the integration of the settings configured on the main unit with the handpiece’s precision injection mechanism, allowing the entire procedure to be managed within a unified system.
Efforts are being stepped up to promote JUVGEN and SDR in overseas markets. To this end, JSDR is collaborating with local medical device distributors and aesthetic medicine professionals, primarily in Asia, and is gradually broadening its export reach by securing necessary regulatory approvals and distribution partners in each country.
Furthermore, by participating in major global aesthetic medicine conferences and exhibitions — such as IMCAS and AMWC— the company introduces international medical professionals to the SDR procedure and JUVGEN’s precision injection technology. The strategy goes beyond mere equipment exports: it aims to introduce the new procedural method itself to overseas markets by simultaneously establishing training programs for medical professionals and building clinical networks.
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods
Leave a Reply